Pub. L. 117-215, tit. III, sec. 301 (as amended)

DOCTOR-PATIENT RELATIONSHIP.

Year: 2022Length: 101 wordsOfficial source
SEC. 301. [21 U.S.C. 801 note] DOCTOR-PATIENT RELATIONSHIP. It shall not be a violation of the Controlled Substances Act (21 U.S.C. 801 et seq.) for a State-licensed physician to discussโ€” (1) the currently known potential harms and benefits of marijuana derivatives, including cannabidiol, as a treatment with the legal guardian of the patient of the physician if the patient is a child; or (2) the currently known potential harms and benefits of marijuana and marijuana derivatives, including cannabidiol, as a treatment with the patient or the legal guardian of the patient of the physician if the patient is a legal adult.
Cross-references to the US Code
21 U.S.C. 801 note
Pub. L. 117-215, tit. III, sec. 301 (as amended): DOCTOR-PATIENT RELATIONSHIP. | Justis AI